David Craig’s operating manual for building biotech companies in today’s market is now available in hardcover and as an ...

CNBC’s Jim Cramer delivers his daily Mad Dash.

VERAXA Biotech (NASDAQ: VRXA) announced the initiation of cell line development for its lead BiTAC(R) T-cell engager ...

Seven life sciences companies cut at least 346 jobs in Massachusetts between April and June, with some of the layoffs tied to ...

A Congressional investigation is looking into whether drug trials in China that involved U.S. companies possibly took place ...

Preview this article 1 min The deal comes days after United Therapeutics received FDA premarket approval for a lung ...

Oral obesity drug with world-first mechanism of action unveiled, drawing strong on-site interestFollowing successful Phase 1 clinical results, global discussions on OVM-200 expandMeetings with over 40 ...

A House committee wants answers from major drugmakers about their China clinical trial practices. The deadline is tighter ...

The chair of the U.S. House Select Committee on China opened national security investigations into whether five drugmakers ...

Equity Insider News Commentary, The scramble to build a critical-minerals supply chain outside China has become one of the ...

Train to Busan’s director just dropped the first look at his return to zombie horror, and it looks absolutely terrifying.

"First they crawled... now they seem to be evolving through information exchange." 🧟 Evolving zombies! Well Go USA has ...